Inspire Medical Systems Revenue and Competitors
Estimated Revenue & Valuation
- Inspire Medical Systems's estimated annual revenue is currently $201M per year.
- Inspire Medical Systems received $75.0M in venture funding in December 2018.
- Inspire Medical Systems's estimated revenue per employee is $212,025
- Inspire Medical Systems's total funding is $319.4M.
- Inspire Medical Systems's current valuation is $6.5B. (January 2022)
Employee Data
- Inspire Medical Systems has 948 Employees.
- Inspire Medical Systems grew their employee count by 86% last year.
Inspire Medical Systems's People
Name | Title | Email/Phone |
---|---|---|
1 | Product Owner | Reveal Email/Phone |
2 | Area VP | Reveal Email/Phone |
3 | Area VP Sales | Reveal Email/Phone |
4 | Zone VP Sales | Reveal Email/Phone |
5 | Area VP | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Area VP Florida | Reveal Email/Phone |
8 | Zone VP | Reveal Email/Phone |
9 | CFO | Reveal Email/Phone |
10 | Area VP | Reveal Email/Phone |
Inspire Medical Systems Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30.6M | 122 | 4% | N/A | N/A |
#2 | $18.6M | 74 | 35% | N/A | N/A |
#3 | $75.6M | 301 | 20% | N/A | N/A |
#4 | $12M | 48 | 4% | N/A | N/A |
#5 | $2.8M | 11 | 10% | N/A | N/A |
#6 | $3M | 12 | 0% | N/A | N/A |
#7 | $24.6M | 98 | 5% | N/A | N/A |
#8 | $11.5M | 46 | 21% | N/A | N/A |
#9 | $7.3M | 29 | 4% | N/A | N/A |
#10 | $13.8M | 55 | -10% | N/A | N/A |
What Is Inspire Medical Systems?
Inspire Medical Systems, Inc. has developed the world's first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient's unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Inspire therapy works inside your body, and with your natural breathing process. It might be right for you if you have been diagnosed with OSA, and can't use or don't get relief from CPAP/BiPAP. To learn more, please visit us at www.inspiresleep.com.
keywords:Biotechnology,Hardware,Healthcare,Medical Devices,Pharmaceuticals$319.4M
Total Funding
948
Number of Employees
$201M
Revenue (est)
86%
Employee Growth %
$6.5B
Valuation
N/A
Accelerator
Inspire Medical Systems News
Sleep apnea treatment developer Inspire Medical Systems has invested in two private companies with digital health tech that could better...
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for...
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for...
On the cover: No mask. No hose. Just sleep. Inspire patients remember their "Inspire Day," the day they received Inspire therapy, as a life changing day. For many it feels almost like a second birthday. An Inspire Day is a turning point-a day when those who have struggled with untreated obstru ...
On the cover: No mask. No hose. Just sleep. Inspire patients remember their "Inspire Day," the day they received Inspire therapy, as a life changing day. For many it feels almost like a second birthday. An Inspire Day is a turning point-a day when those who have struggled with untreated obstru ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $307.1M | 1567 | 4% | N/A |
#2 | $794.2M | 1607 | 79% | N/A |
#3 | $694.5M | 2756 | N/A | N/A |
Inspire Medical Systems Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2014-05-16 | $40.0M | E | OrbiMed | Article |
2016-11-10 | $12.5M | Undisclosed | Article | |
2016-11-21 | $37.5M | F | Amzak Health | Article |
2018-12-19 | $75.0M | Undisclosed | Article |